Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,148 | 41,666 | 86,097 | 21,993 | 15,566 |
| Marketable Securities | 468,961 | 428,504 | 232,296 | 329,954 | 265,223 |
| TOTAL | $543,385 | $475,483 | $326,997 | $356,999 | $283,773 |
| Non-Current Assets | |||||
| PPE Net | 7,831 | 9,503 | 10,443 | 8,533 | 912 |
| Other Non-Current Assets | 1,387 | 1,831 | 2,595 | 1,569 | 548 |
| TOTAL | $9,218 | $11,334 | $13,038 | $10,102 | $1,460 |
| Total Assets | $552,603 | $486,817 | $340,035 | $367,101 | $285,233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,006 | 5,579 | 4,025 | 6,105 | 3,843 |
| TOTAL | $27,370 | $23,860 | $16,771 | $16,585 | $10,521 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,976 | 3,741 | 4,434 | 3,800 | 329 |
| TOTAL | $2,976 | $3,741 | $4,434 | $3,800 | $329 |
| Total Liabilities | $30,346 | $27,601 | $21,205 | $20,385 | $10,850 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,271 | 95,205 | 93,111 | 63,262 | 49,512 |
| Common Shares | 10 | 9 | 7 | 6 | 5 |
| Retained earnings | -546,371 | -378,576 | -244,763 | -144,600 | -76,960 |
| Other shareholders' equity | 677 | 420 | 99 | -1,355 | -514 |
| TOTAL | $522,257 | $459,216 | $318,830 | $346,716 | $274,383 |
| Total Liabilities And Equity | $552,603 | $486,817 | $340,035 | $367,101 | $285,233 |